Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Determinants of long-term survival from atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 28, 2025
Patient Blood Management in Cancer Surgery.
Journal: International anesthesiology clinics
Published: October 30, 2025
Reproducible safety and efficacy of durvalumab with or without tremelimumab for hepatocellular carcinoma in clinical practice: Results of the DT-real study.
Journal: JHEP reports : innovation in hepatology
Published: July 04, 2025
Challenges and practical considerations in the management of blastic plasmacytoid dendritic cell neoplasm: A single-center experience.
Journal: Leukemia research reports
Published: October 07, 2024
The use of advanced machine learning to predict outcomes after atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: a retrospective cohort study.
Journal: The Lancet. Digital health
Published: October 01, 2024
A second look at the mortality in thrombotic thrombocytopenic purpura score: An external validation study.
Journal: Transfusion medicine (Oxford, England)
Published: July 14, 2022
Hemophagocytic Lymphohistiocytosis Secondary to Immune Checkpoint Inhibitor Therapy.
Journal: World journal of oncology
Published: February 26, 2022
Showing 1-7 of 7
Last Updated: 09/26/2026